COVID 19 all comers | COVID-19 mild to moderate | ||
COVID 19 hospitalized | COVID 19 all comers | COVID-19 mild to moderate | |
Renin-angiotensin-system-acting agents | Bean Zhang Li Meng Yan et al. Yang | ||
angiotensin receptor blockers (ARBs) | Nouri-Vaskeh Duarte | ||
losartan | University of Minnesota | ||
discontinuation of ACEI/ARB | Najmeddin REPLACE | Lopes ... |
5347 | Mehra, 2020 | 2 | 12 | 4 | excluded | not a RCT | high risk of bias |